Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity Reporting to the Director, Analytics and Insights, the Associate Director, US Field Analytics will serve as a key analytics partner to Revolution Medicines’ field organization and Commercial leadership. This role combines strong hands-on analytical capabilities with strategic thinking and business partnership to improve field strategy, deployment, execution, and performance. The Associate Director will support RevMed field teams broadly, leading analytics and insights across areas including segmentation and targeting, field performance measurement, dashboards and reporting, territory design and alignment, and resource optimization. The successful candidate will be equally comfortable working directly with complex data and partnering with senior business leaders by translating business questions into clear, actionable recommendations through rigorous analysis.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level